Kuwabara Ren, Hara Kazuo, Haba Shin, Kuwahara Takamichi, Okuno Nozomi, Koda Hiroki, Urata Minako, Kondo Takashi, Yamamoto Yoshitaro, Oshiro Keigo, Ogata Tomoki
Department of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan.
J Clin Med. 2025 May 28;14(11):3773. doi: 10.3390/jcm14113773.
: Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) using a fully covered self-expandable metal stent (FCSEMS) is an alternative to endoscopic retrograde cholangiopancreatography for biliary drainage; however, FCSEMSs may cause intrahepatic bile duct (IHD) obstruction and cholangitis. In this study, we developed an FCSEMS with multiple self-made side holes at its tip and evaluated its safety and efficacy. : This retrospective study included 100 patients who underwent EUS-HGS with FCSEMS placement between April 2022 and October 2023. Fifty patients received a conventional FCSEMS, and 50 received an FCSEMS with multiple self-made side holes. Technical and clinical success, residual contrast in the IHD, recurrent biliary obstruction (RBO), and adverse events (AEs) were then evaluated. The clinical success rates were 98% and 90% for the side hole and conventional FCEMS groups, respectively. The amount of residual contrast in the IHD was lower in the side hole group (0% vs. 12%, = 0.027). RBO incidence was significantly lower in the side hole group (8% vs. 30%, < 0.001), with migration as the primary cause in the conventional group. Early AEs, including segmental cholangitis, occurred only in the conventional group. During reintervention, all stents were safely removed. : The FCSEMSs with multiple side holes reduced IHD occlusion and cholangitis, improving biliary drainage and safety. Further studies are needed to confirm these findings.
使用全覆膜自膨式金属支架(FCSEMS)的内镜超声引导下肝胃吻合术(EUS-HGS)是内镜逆行胰胆管造影术用于胆道引流的一种替代方法;然而,FCSEMS可能导致肝内胆管(IHD)梗阻和胆管炎。在本研究中,我们研发了一种在其尖端有多个自制侧孔的FCSEMS,并评估了其安全性和有效性。 这项回顾性研究纳入了2022年4月至2023年10月期间接受EUS-HGS并置入FCSEMS的100例患者。50例患者接受了传统FCSEMS,50例接受了带有多个自制侧孔的FCSEMS。然后评估技术和临床成功率、IHD中的残留造影剂、复发性胆道梗阻(RBO)和不良事件(AE)。侧孔组和传统FCEMS组的临床成功率分别为98%和90%。侧孔组IHD中的残留造影剂量较低(0%对12%,P = 0.027)。侧孔组的RBO发生率显著较低(8%对30%,P < 0.001),传统组中迁移是主要原因。早期AE,包括节段性胆管炎,仅发生在传统组。在再次干预期间,所有支架均安全取出。 带有多个侧孔的FCSEMS减少了IHD阻塞和胆管炎,改善了胆道引流和安全性。需要进一步研究来证实这些发现。